Amedisys sinks after report DOJ leaning toward challenging UnitedHealth deal
AMED Stock | USD 85.15 0.08 0.09% |
About 55% of Amedisys' investor base is interested to short. The analysis of overall sentiment of trading Amedisys stock suggests that many investors are impartial at this time. The current market sentiment, together with Amedisys' historical and current headlines, can help investors time the market. In addition, many technical investors use Amedisys stock news signals to limit their universe of possible portfolio assets.
Amedisys |
Amedisys stock drops 6 percent after report DOJ may challenge UnitedHealthcare acquisition. Traders cite Capitol Forum report.
Read at seekingalpha.com
Amedisys Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Amedisys can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Amedisys Fundamental Analysis
We analyze Amedisys' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Amedisys using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Amedisys based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Gross Profit
Gross Profit Comparative Analysis
Amedisys is currently under evaluation in gross profit category among its peers. Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Amedisys Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Amedisys stock to make a market-neutral strategy. Peer analysis of Amedisys could also be used in its relative valuation, which is a method of valuing Amedisys by comparing valuation metrics with similar companies.
Peers
Amedisys Related Equities
HCSG | Healthcare Services | 3.51 | ||||
UHS | Universal Health | 0.62 | ||||
ACHC | Acadia Healthcare | 0.45 | ||||
PNTG | Pennant | 0.41 | ||||
EHAB | Enhabit | 0.13 | ||||
ENSG | Ensign | 0.1 | ||||
ADUS | Addus HomeCare | 0.02 | ||||
EHC | Encompass Health | 0.30 | ||||
SGRY | Surgery Partners | 0.43 | ||||
OPCH | Option Care | 0.44 | ||||
NHC | National HealthCare | 0.52 | ||||
INNV | InnovAge Holding | 3.10 |
Complementary Tools for Amedisys Stock analysis
When running Amedisys' price analysis, check to measure Amedisys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amedisys is operating at the current time. Most of Amedisys' value examination focuses on studying past and present price action to predict the probability of Amedisys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amedisys' price. Additionally, you may evaluate how the addition of Amedisys to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |